Ticker Symbol: NVIV
InVivo Therapeutics Holdings Corp
$0.54 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001292519
Company Profile
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children's Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 1 Kendall Sq Fl 4
Website: www.invivotherapeutics.com
CEO: Richard Toselli
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $1.02
Change:
-$0.02
(
-1.91%)
Days Range: $1.02 - $1.04
Beta: 1.11
52wk. High: $3.06
52wk. Low: $0.80
Ytd. Change -58.09%
50 Day Moving Average: $1.12
200 Day Moving Average: $1.24
Shares Outstanding: 3105446
Valuation
Market Cap: 319.8M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A